Search Results - Paul Frohna
- Showing 1 - 1 results of 1
-
1
715 ICT01 plus low dose SC IL-2 produces a robust anti-tumor immune activation in advanced cancer patients (EVICTION-2 Study) by Stephane Champiat, Francois-Xavier Danlos, Volker Kunzmann, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Johann De Bono, Paul Frohna, Marina Iché, Maelle Mairesse, Celine Leparquier, Katrien Lemmens
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article